{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T02:46:59Z","timestamp":1783478819672,"version":"3.55.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2015,5,12]],"date-time":"2015-05-12T00:00:00Z","timestamp":1431388800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Osteoporos Int"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1007\/s00198-015-3136-8","type":"journal-article","created":{"date-parts":[[2015,5,11]],"date-time":"2015-05-11T13:55:32Z","timestamp":1431352532000},"page":"2193-2202","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":56,"title":["Role of vitamin D levels and vitamin D supplementation on bone mineral density in Klinefelter syndrome"],"prefix":"10.1007","volume":"26","author":[{"given":"A.","family":"Ferlin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Selice","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Di Mambro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Ghezzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Di Nisio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Caretta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Foresta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,5,12]]},"reference":[{"key":"3136_CR1","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S0140-6736(04)16678-6","volume":"364","author":"F Lanfranco","year":"2004","unstructured":"Lanfranco F, Kamischke A, Zitzmann M, Nieschlag E (2004) Klinefelter\u2019s syndrome. Lancet 364:273\u2013283","journal-title":"Lancet"},{"key":"3136_CR2","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1210\/jcem-2-11-615","volume":"2","author":"HF Klinefelter","year":"1942","unstructured":"Klinefelter HF, Reifenstein EC, Albright F (1942) Syndrome characterized by gynecomastia, aspermatogenesis without a-Leydigism, and increased excretion of follicle-stimulating hormone. J Clin Endocrinol Metab 2:615\u2013627","journal-title":"J Clin Endocrinol Metab"},{"key":"3136_CR3","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/j.1399-0004.1981.tb00709.x","volume":"19","author":"WA Campbell","year":"1981","unstructured":"Campbell WA, Price WH (1981) Venous thromboembolic disease in Klinefelter\u2019s syndrome. Clin Genet 19:275\u201380","journal-title":"Clin Genet"},{"key":"3136_CR4","doi-asserted-by":"crossref","first-page":"6516","DOI":"10.1210\/jc.2005-1077","volume":"90","author":"AJ Swerdlow","year":"2005","unstructured":"Swerdlow AJ, Higgin CD, Schomaker MJ, Wright AF, Jacobs PA (2005) Mortality in patients with Klinefelter\u2019s syndrome in Britain: a cohort study. J Clin Endocrinol Metab 90:6516\u20136522","journal-title":"J Clin Endocrinol Metab"},{"key":"3136_CR5","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1111\/j.1651-2227.2011.02274.x","volume":"100","author":"A Bojesen","year":"2011","unstructured":"Bojesen A, Gravholt CH (2011) Morbidity and mortality in Klinefelter syndrome (47XXY). Acta Paediatr 100:807\u201313","journal-title":"Acta Paediatr"},{"key":"3136_CR6","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1055\/s-0029-1211192","volume":"100","author":"A K\u00fcbler","year":"1992","unstructured":"K\u00fcbler A, Schulz G, Cordes U, Beyer J, Krause U (1992) The influence of testosterone substitution on bone mineral density in patients with Klinefelter\u2019s syndrome. Exp Clin Endocrinol 100:129\u2013132","journal-title":"Exp Clin Endocrinol"},{"key":"3136_CR7","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/S1297-319X(00)00235-9","volume":"68","author":"V Breuil","year":"2001","unstructured":"Breuil V, Euller-Ziegler L (2001) Gonadal dysgenesis and bone metabolism. Joint Bone Spine 68:26\u201333","journal-title":"Joint Bone Spine"},{"key":"3136_CR8","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s001980170158","volume":"12","author":"JP Bergh van den","year":"2001","unstructured":"van den Bergh JP, Hermus AR, Spruyt AI, Sweep CG, Corstens FH, Smals AG (2001) Bone mineral density and quantitative ultrasound parameters in patients with Klinefelter\u2019s syndrome after long-term testosterone substitution. Osteoporos Int 12:55\u201362","journal-title":"Osteoporos Int"},{"issue":"4","key":"3136_CR9","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1210\/jc.2010-1878","volume":"96","author":"A Ferlin","year":"2011","unstructured":"Ferlin A, Schipilliti M, Vinanzi C, Garolla A, Di Mambro A, Selice R, Lenzi A, Foresta C (2011) Bone mass in subjects with Klinefelter syndrome: role of testosterone levels and androgen receptor gene CAG polymorphism. J Clin Endocrinol Metab 96(4):739\u201345","journal-title":"J Clin Endocrinol Metab"},{"key":"3136_CR10","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1007\/BF01626608","volume":"5","author":"G Luisetto","year":"1995","unstructured":"Luisetto G, Mastrogiacomo I, Bonanni G, Pozzan G, Botteon S, Tizian L, Galuppo P (1995) Bone mass and mineral metabolism in Klinefelter\u2019s syndrome. Osteoporos Int 5:455\u2013461","journal-title":"Osteoporos Int"},{"key":"3136_CR11","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1007\/s00198-010-1354-7","volume":"22","author":"A Bojesen","year":"2011","unstructured":"Bojesen A, Birkeb\u00e6k N, Kristensen K, Heickendorff L, Mosekilde L, Christiansen JS, Gravholt CH (2011) Bone mineral density in Klinefelter syndrome is reduced and primarily determined by muscle strength and resorptive markers, but not directly by testosterone. Osteoporos Int 22:1441\u201350","journal-title":"Osteoporos Int"},{"issue":"6","key":"3136_CR12","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.3349\/ymj.2013.54.6.1331","volume":"54","author":"DG Jo","year":"2013","unstructured":"Jo DG, Lee HS, Joo YM, Seo JT (2013) Effect of testosterone replacement therapy on bone mineral density in patients with Klinefelter syndrome. Yonsei Med J 54(6):1331\u20135","journal-title":"Yonsei Med J"},{"key":"3136_CR13","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1055\/s-2007-1018630","volume":"15","author":"C Foresta","year":"1983","unstructured":"Foresta C, Ruzza G, Mioni R, Meneghello A, Baccichetti C (1983) Testosterone and bone loss in Klinefelter syndrome. Horm Metab Res 15:56\u201357","journal-title":"Horm Metab Res"},{"key":"3136_CR14","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/j.1365-2265.1992.tb02910.x","volume":"36","author":"M Horowitz","year":"1992","unstructured":"Horowitz M, Wishart JM, O\u2019Loughlin PD, Morris HA, Need AG, Nordin BE (1992) Osteoporosis and Klinefelter\u2019s syndrome. Clin Endocrinol (Oxf) 36:113\u2013118","journal-title":"Clin Endocrinol (Oxf)"},{"key":"3136_CR15","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/j.1464-410X.2006.06584.x","volume":"99","author":"JT Seo","year":"2007","unstructured":"Seo JT, Lee JS, OhTH JKJ (2007) The clinical significance of bone mineral density and testosterone levels in Korean men with non mosaic Klinefelter\u2019s syndrome. BJU Int 99:141\u2013146","journal-title":"BJU Int"},{"key":"3136_CR16","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/BF01623169","volume":"3","author":"FH Wong","year":"1993","unstructured":"Wong FH, Pun KK, Wang C (1993) Loss of bone mass in patients with Klinefelter\u2019s syndrome despite sufficient testosterone replacement. Osteoporos Int 3:3\u20137","journal-title":"Osteoporos Int"},{"key":"3136_CR17","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/s00394-012-0430-5","volume":"52","author":"S Battault","year":"2013","unstructured":"Battault S, Whiting SJ, Peltier SL, Sadrin S, Gerber G, Maixent JM (2013) Vitamin D metabolism, functions and needs: from science to health claims. Eur J Nutr 52:429\u2013441","journal-title":"Eur J Nutr"},{"key":"3136_CR18","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1210\/edrv.22.4.0437","volume":"22","author":"P Lips","year":"2001","unstructured":"Lips P (2001) Vitamin D deficiency and secondary hyperparathyroidism in the elderly: consequences for bone loss and fractures and therapeutic implications. Endocr Rev 22:477\u2013501","journal-title":"Endocr Rev"},{"key":"3136_CR19","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.abb.2005.02.001","volume":"436","author":"D Choudhary","year":"2005","unstructured":"Choudhary D, Jansson I, Stoilov I, Sarfarazi M, Schenkman JB (2005) Expression patterns of mouse and human CYP orthologs (families 1\u20134) during development and in different adult tissues. Arch Biochem Biophys 436:50\u201361","journal-title":"Arch Biochem Biophys"},{"key":"3136_CR20","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1093\/humrep\/deq024","volume":"25","author":"M Blomberg Jensen","year":"2010","unstructured":"Blomberg Jensen M, Nielsen JE, J\u00f8rgensen A, Rajpert-De Meyts E, Kristensen DM, J\u00f8rgensen N, Skakkebaek NE, Juul A, Leffers H (2010) Vitamin D receptor and vitamin D metabolizing enzymes are expressed in the human male reproductive tract. Hum Reprod 25:1303\u201311","journal-title":"Hum Reprod"},{"key":"3136_CR21","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1038\/nrendo.2013.135","volume":"9","author":"A Ferlin","year":"2013","unstructured":"Ferlin A, Selice R, Carraro U, Foresta C (2013) Testicular function and bone metabolism\u2014beyond testosterone. Nat Rev Endocrinol 9:548\u201354","journal-title":"Nat Rev Endocrinol"},{"key":"3136_CR22","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1210\/jc.2005-2847","volume":"91","author":"S Bhasin","year":"2006","unstructured":"Bhasin S, Cunningham GR, Hayes FJ, Matsumoto AM, Snyder PJ, Swerdloff RS, Montori VM (2006) Testosterone therapy in adult men with androgen deficiency syndromes: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 91:1995\u20132010","journal-title":"J Clin Endocrinol Metab"},{"key":"3136_CR23","first-page":"94","volume":"10","author":"WB Grant","year":"2005","unstructured":"Grant WB, Holick MF (2005) Benefits and requirements of vitamin D for optimal health: a review. Altern Med Rev 10:94\u2013111","journal-title":"Altern Med Rev"},{"key":"3136_CR24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1385\/JCD:7:1:1","volume":"7","author":"ES Leib","year":"2004","unstructured":"Leib ES, Lewiecki EM, Binkley N, Hamdy RC, International Society for Clinical Densitometry (2004) Official positions of the international society for clinical densitometry. J Clin Densitom 7:1\u20136","journal-title":"J Clin Densitom"},{"key":"3136_CR25","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1093\/molehr\/gaq026","volume":"16","author":"A Ferlin","year":"2010","unstructured":"Ferlin A, Schipilliti M, Di Mambro A, Vinanzi C, Foresta C (2010) Osteoporosis in Klinefelter\u2019s syndrome. Mol Hum Reprod 16:402\u2013410","journal-title":"Mol Hum Reprod"},{"key":"3136_CR26","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.cnur.2006.11.004","volume":"42","author":"JH Romeo","year":"2007","unstructured":"Romeo JH, Ybarra J (2007) Hypogonadal hypogonadism and osteoporosis in men. Nurs Clin North Am 42:87\u201399, vii-viii","journal-title":"Nurs Clin North Am"},{"issue":"Suppl 6","key":"3136_CR27","first-page":"S30","volume":"6","author":"K Dupree","year":"2004","unstructured":"Dupree K, Dobs A (2004) Osteopenia and male hypogonadism. Rev Urol 6(Suppl 6):S30\u2013S34","journal-title":"Rev Urol"},{"key":"3136_CR28","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/1096-8628(20010101)98:1<25::AID-AJMG1015>3.0.CO;2-X","volume":"98","author":"Y Iitsuka","year":"2001","unstructured":"Iitsuka Y, Bock A, Nguyen DD, Samango-Sprouse CA, Simpson JL, Bischoff FZ (2001) Evidence of skewed X-chromosome inactivation in 47,XXY and 48,XXYY Klinefelter patients. Am J Med Genet 98:25\u201331","journal-title":"Am J Med Genet"},{"key":"3136_CR29","doi-asserted-by":"crossref","first-page":"3181","DOI":"10.1093\/nar\/22.15.3181","volume":"22","author":"NL Chamberlain","year":"1994","unstructured":"Chamberlain NL, Driver ED, Miesfeld RL (1994) The length and location of CAG trinucleotide repeats in the androgen receptor N-terminal domain affect transactivation function. Nucleic Acids Res 22:3181\u20133186","journal-title":"Nucleic Acids Res"},{"key":"3136_CR30","doi-asserted-by":"crossref","first-page":"6208","DOI":"10.1210\/jc.2004-1424","volume":"89","author":"M Zitzmann","year":"2004","unstructured":"Zitzmann M, Depenbusch M, Gromoll J, Nieschlag E (2004) X-chromosome inactivation patterns and androgen receptor functionality influence phenotype and social characteristics as well as pharmacogenetics of testosterone therapy in Klinefelter patients. J Clin Endocrinol Metab 89:6208\u20136217","journal-title":"J Clin Endocrinol Metab"},{"key":"3136_CR31","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1111\/j.2047-2927.2014.00204.x","volume":"2","author":"S Overvad","year":"2014","unstructured":"Overvad S, Bay K, Bojesen A, Gravholt CH (2014) Low INSL3 in Klinefelter syndrome is related to osteocalcin, testosterone treatment and body composition, as well as measures of the hypothalamic-pituitary-gonadal axis. Andrology 2:421\u20137","journal-title":"Andrology"},{"key":"3136_CR32","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1210\/jc.2010-1628","volume":"96","author":"C Foresta","year":"2011","unstructured":"Foresta C, Strapazzon G, De Toni L, Perilli L, Di Mambro A, Muciaccia B, Sartori L, Selice R (2011) Bone mineral density and testicular failure: evidence for a role of vitamin D 25-hydroxylase in human testis. J Clin Endocrinol Metab 96:646\u201352","journal-title":"J Clin Endocrinol Metab"},{"key":"3136_CR33","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/S0140-6736(10)61916-2","volume":"376","author":"C Foresta","year":"2010","unstructured":"Foresta C, Selice R, Di Mambro A, Strapazzon G (2010) Testiculopathy and vitamin D insufficiency. Lancet 376:1301","journal-title":"Lancet"},{"key":"3136_CR34","first-page":"379","volume":"36","author":"C Foresta","year":"2013","unstructured":"Foresta C, Selice R, De Toni L, Di Mambro A, Carraro U, Plebani M, Garolla A (2013) Altered bone status in unilateral testicular cancer survivors: role of CYP2R1 and its luteinizing hormone-dependency. J Endocrinol Invest 36:379\u201384","journal-title":"J Endocrinol Invest"},{"key":"3136_CR35","author":"C Foresta","year":"2014","unstructured":"Foresta C, Calogero AE, Lombardo F, Lenzi A, Ferlin A (2014) Late-onset hypogonadism\u2014beyond testosterone. Asian J Androl. doi: 10.4103\/1008-682X.135985","journal-title":"Asian J Androl"},{"key":"3136_CR36","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1210\/jc.2007-1217","volume":"93","author":"MT Hannan","year":"2008","unstructured":"Hannan MT, Litman HJ, Araujo AB, McLennan CE, McLean RR, McKinlay JB, Chen TC, Holick MFS (2008) Serum 25-hydroxyvitamin D and bone mineral density in a racially and ethnically diverse group of men. J Clin Endocrinol Metab 93:40\u20136","journal-title":"J Clin Endocrinol Metab"},{"key":"3136_CR37","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.1007\/s00198-010-1481-1","volume":"22","author":"KE Barbour","year":"2011","unstructured":"Barbour KE, Zmuda JM, Horwitz MJ, Strotmeyer ES, Boudreau R, Evans RW, Ensrud KE, Gordon CL, Petit MA, Patrick AL, Cauley JA (2011) Osteoporotic fractures in men (MrOS) research group. The association of serum 25-hydroxyvitamin D with indicators of bone quality in en of Caucasian and African ancestry. Osteoporos Int 22:2475\u201385","journal-title":"Osteoporos Int"},{"key":"3136_CR38","doi-asserted-by":"crossref","unstructured":"Reid IR, Bolland MJ (2014) Skeletal and nonskeletal effects of vitamin D: is vitamin D a tonic for bone and other tissues? Osteoporos Int. May 21. [Epub ahead of print]","DOI":"10.1007\/s00198-014-2749-7"},{"key":"3136_CR39","first-page":"1","volume":"158","author":"A Cranney","year":"2007","unstructured":"Cranney A, Horsley T, O\u2019Donnell S, Weiler H, Puil L, Ooi D, Atkinson S, Ward L, Moher D, Hanley D, Fang M, Yazdi F, Garritty C, Sampson M, Barrowman N, Tsertsvadze A, Mamaladze V (2007) Effectiveness and safety of vitamin D in relation to bone health. Evid Rep Technol Assess (Full Rep) 158:1\u2013235","journal-title":"Evid Rep Technol Assess (Full Rep)"},{"key":"3136_CR40","first-page":"955","volume":"155","author":"G Jones","year":"1996","unstructured":"Jones G, Hogan DB, Yendt E, Hanley DA (1996) Prevention and management of osteoporosis: consensus statements from the Scientific Advisory Board of the osteoporosis Society of Canada. 8. Vitamin D metabolites and analogs in the treatment of osteoporosis. CMAJ 155:955\u201361","journal-title":"CMAJ"},{"key":"3136_CR41","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1210\/er.2001-8002","volume":"23","author":"E Papadimitropoulos","year":"2002","unstructured":"Papadimitropoulos E, Wells G, Shea B, Gillespie W, Weaver B, Zytaruk N, Cranney A, Adachi J, Tugwell P, Josse R, Greenwood C, Guyatt G, Osteoporosis Methodology Group and The Osteoporosis Research Advisory Group (2002) Meta-analyses of therapies for postmenopausal osteoporosis. VIII: Meta-analysis of the efficacy of vitamin D treatment in preventing osteoporosis in postmenopausal women. Endocr Rev 23:560\u20139","journal-title":"Endocr Rev"},{"key":"3136_CR42","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1001\/jama.293.18.2257","volume":"293","author":"HA Bischoff-Ferrari","year":"2005","unstructured":"Bischoff-Ferrari HA, Willett WC, Wong JB, Giovannucci E, Dietrich T, Dawson-Hughes B (2005) Fracture prevention with vitamin D supplementation: a meta-analysis of randomized controlled trials. JAMA 293:2257\u201364","journal-title":"JAMA"}],"container-title":["Osteoporosis International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-015-3136-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00198-015-3136-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-015-3136-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T15:15:22Z","timestamp":1558624522000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00198-015-3136-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5,12]]},"references-count":42,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2015,8]]}},"alternative-id":["3136"],"URL":"https:\/\/doi.org\/10.1007\/s00198-015-3136-8","relation":{},"ISSN":["0937-941X","1433-2965"],"issn-type":[{"value":"0937-941X","type":"print"},{"value":"1433-2965","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,5,12]]}}}